Luye Pharma Group Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Luye Pharma Group stock has a consensus rating of "Buy" and an average price target of $3.53. The average 1-year stock price forecast is 78.28% higher than the current stock price, while the lowest is $2.72 (+37.37%) and the highest is $4.34 (+119.19%).

Price Target: $3.53 (+78.28%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.72	$3.53	$3.53	$4.34
Change	+37.37%	+78.28%	+78.28%	+119.19%

* Price targets were last updated on Apr 19, 2026.

Analyst Ratings

The average analyst rating for Luye Pharma Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Apr '25	Jul '25	Sep '25	Dec '25	Feb '26	Apr '26
Strong Buy	1	1	2	2	2	1
Buy	0	0	0	0	0	0
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	4	3	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst SDIC Securities No rating	SDIC Securities	Buy Maintains $4.34	Buy	Maintains	$4.34	+119.19%	Apr 19, 2026
Unknown Analyst Citi No rating	Citi	Buy Maintains $4.30	Buy	Maintains	$4.30	+117.17%	Apr 13, 2026

Financial Forecast

Revenue This Year

6.82B

from 6.31B

8.17%

from 6.31B

Revenue Next Year

7.33B

from 6.82B

7.45%

from 6.82B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	5.20B	5.98B	6.14B	6.06B	6.31B	6.82B
Revenue Growth	-6.13%	15.03%	2.70%	-1.33%	4.07%	8.17%
Gross Profit	3.40B	4.14B	4.20B	4.04B	4.16B	4.62B
Gross Margin	65.32%	69.22%	68.44%	66.72%	65.99%	67.70%
Operating Income	363.40M	789.14M	887.44M	1.14B	1.22B	1.50B
Net Income	-134.39M	604.81M	532.61M	471.89M	618.75M	662.78M
Free Cash Flow	-778.54M	-43.00M	629.06M	-2.50B	-692.81M	1.44B
No. Analysts	-	-	-	-	-	2

Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	7.2B
Avg	6.8B
Low	6.5B

Revenue Growth

Revenue Growth	2026	2027	2028
High	13.6%
Avg	8.2%
Low	2.8%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-